Silo Pharma, Inc. - Common Stock (NQ:SILO)

0.2867 -0.0033 (-1.14%)

Streaming Delayed Price Updated: 2:38 PM EST, Feb 20, 2026 Add to My Watchlist

Price and Volume

Volume	69,065
Open	0.2900
Bid (Size)	0.2867 (100)
Ask (Size)	0.2869 (100)
Prev. Close	0.2900
Today's Range	0.2830 - 0.2941
52wk Range	0.2210 - 1.520
Shares Outstanding	98,671,970
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives Japan Patent Allowance for SPC-15 PTSD Candidate10

February 18, 2026

Via Investor Brand Network

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

February 18, 2026

Patent strengthens protection for novel PTSD drug and advances the Company’s international IP strategy

From Silo Pharma, Inc.

Via GlobeNewswire

Performance

YTD	-14.6%	-14.6%
1 Month	-20.7%	-20.7%
3 Month	-21.1%	-21.1%
6 Month	-57.0%	-57.0%
1 Year	-80.9%	-80.9%

More News

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

December 30, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

November 17, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

October 29, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

October 23, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth

October 08, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

October 06, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

October 01, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Stay updated with the stocks that are on the move in today's pre-market session. ↗

September 30, 2025

Via Chartmill

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

September 30, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management

September 29, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

These stocks are gapping in today's session ↗

September 23, 2025

Via Chartmill

Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security

September 23, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

EXCLUSIVE: Silo Pharma Partners With Fireblocks To Advance Crypto Treasury Strategy Acquisition And Security ↗

September 23, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

September 16, 2025

Via Chartmill

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

September 16, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗

September 09, 2025

Via MarketBeat

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

September 09, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

September 03, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers ↗

September 02, 2025

Via Benzinga

Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

August 21, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 19, 2025

Via Benzinga

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

August 19, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

August 05, 2025

From Silo Pharma, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Silo Pharma, Inc. - Common Stock publicly traded?

Yes, Silo Pharma, Inc. - Common Stock is publicly traded.

What exchange does Silo Pharma, Inc. - Common Stock trade on?

Silo Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Silo Pharma, Inc. - Common Stock?

The ticker symbol for Silo Pharma, Inc. - Common Stock is SILO on the Nasdaq Stock Market

What is the current price of Silo Pharma, Inc. - Common Stock?

The current price of Silo Pharma, Inc. - Common Stock is 0.2867

When was Silo Pharma, Inc. - Common Stock last traded?

The last trade of Silo Pharma, Inc. - Common Stock was at 02/20/26 02:38 PM ET

What is the market capitalization of Silo Pharma, Inc. - Common Stock?

The market capitalization of Silo Pharma, Inc. - Common Stock is 28.29M

How many shares of Silo Pharma, Inc. - Common Stock are outstanding?

Silo Pharma, Inc. - Common Stock has 28M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.